273 related articles for article (PubMed ID: 18502465)
1. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells.
Arsenio J; Deschambault Y; Cao J
Virology; 2008 Jul; 377(1):124-32. PubMed ID: 18502465
[TBL] [Abstract][Full Text] [Related]
2. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses.
Beattie E; Paoletti E; Tartaglia J
Virology; 1995 Jul; 210(2):254-63. PubMed ID: 7542414
[TBL] [Abstract][Full Text] [Related]
4. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.
Beattie E; Denzler KL; Tartaglia J; Perkus ME; Paoletti E; Jacobs BL
J Virol; 1995 Jan; 69(1):499-505. PubMed ID: 7527085
[TBL] [Abstract][Full Text] [Related]
5. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA.
Chang HW; Jacobs BL
Virology; 1993 Jun; 194(2):537-47. PubMed ID: 8099244
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.
Brandt T; Heck MC; Vijaysri S; Jentarra GM; Cameron JM; Jacobs BL
Virology; 2005 Mar; 333(2):263-70. PubMed ID: 15721360
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L.
Langland JO; Jacobs BL
Virology; 2004 Jul; 324(2):419-29. PubMed ID: 15207627
[TBL] [Abstract][Full Text] [Related]
8. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.
Xiang Y; Condit RC; Vijaysri S; Jacobs B; Williams BR; Silverman RH
J Virol; 2002 May; 76(10):5251-9. PubMed ID: 11967338
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
10. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L.
Shors T; Kibler KV; Perkins KB; Seidler-Wulff R; Banaszak MP; Jacobs BL
Virology; 1997 Dec; 239(2):269-76. PubMed ID: 9434718
[TBL] [Abstract][Full Text] [Related]
11. Complementation of deletion of the vaccinia virus E3L gene by the Escherichia coli RNase III gene.
Shors T; Jacobs BL
Virology; 1997 Jan; 227(1):77-87. PubMed ID: 9007060
[TBL] [Abstract][Full Text] [Related]
12. The interferon system and vaccinia virus evasion mechanisms.
Perdiguero B; Esteban M
J Interferon Cytokine Res; 2009 Sep; 29(9):581-98. PubMed ID: 19708815
[TBL] [Abstract][Full Text] [Related]
13. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
Ramsey-Ewing AL; Moss B
Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
[TBL] [Abstract][Full Text] [Related]
14. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
[TBL] [Abstract][Full Text] [Related]
15. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene.
Yuwen H; Cox JH; Yewdell JW; Bennink JR; Moss B
Virology; 1993 Aug; 195(2):732-44. PubMed ID: 8337842
[TBL] [Abstract][Full Text] [Related]
17. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo.
Vijaysri S; Talasela L; Mercer AA; Mcinnes CJ; Jacobs BL; Langland JO
Virology; 2003 Sep; 314(1):305-14. PubMed ID: 14517083
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus recombinants as a model system to analyze interferon-induced pathways.
Gil J; Esteban M
J Interferon Cytokine Res; 2004 Nov; 24(11):637-46. PubMed ID: 15684816
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.
Rivas C; Gil J; Mĕlková Z; Esteban M; Díaz-Guerra M
Virology; 1998 Apr; 243(2):406-14. PubMed ID: 9568039
[TBL] [Abstract][Full Text] [Related]
20. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
